Adenovirus infections in hematopoietic stem cell transplant recipients
- PMID: 10585802
- DOI: 10.1086/313514
Adenovirus infections in hematopoietic stem cell transplant recipients
Abstract
We report a 12% incidence of adenovirus infections among 532 recipients of hematopoietic stem cell transplant (HSCT) from January 1986 through March 1997. The median time from day of stem cell infusion to first positive culture was 41 days. Recipients of allogeneic stem cells, as opposed to autologous stem cell recipients, were more likely to have a culture positive for adenovirus (16% vs. 3%; P<.0001). Pediatric patients were also more likely than adults to have a positive culture (23% vs. 9%; P<.0001). Among stem cell recipients with partially matched related donors, pediatric recipients appear to be at significantly greater risk for infection than adult recipients (P<.001). Positive cultures were associated with evidence of invasion in 64% of cases (41 of 64). A multiple logistic regression analysis showed that isolating adenovirus from more than 1 site correlated with greater risk for invasive infections (P=.002). Invasive infections were associated with poorer chance of survival.
Similar articles
-
Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database.Clin Infect Dis. 2010 Apr 15;50(8):1091-100. doi: 10.1086/651263. Clin Infect Dis. 2010. PMID: 20218877
-
Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation.Klin Padiatr. 2005 May-Jun;217(3):135-41. doi: 10.1055/s-2005-836509. Klin Padiatr. 2005. PMID: 15858704
-
Quantification of adenovirus DNA in unrelated donor hematopoietic stem cell transplant recipients.J Clin Virol. 2008 Sep;43(1):79-85. doi: 10.1016/j.jcv.2008.04.014. Epub 2008 Jun 11. J Clin Virol. 2008. PMID: 18550426
-
Adenovirus infections in heart transplantation.Cardiol Rev. 2013 Jul-Aug;21(4):203-6. doi: 10.1097/CRD.0b013e31828da5b7. Cardiol Rev. 2013. PMID: 23535527 Review.
-
Adenoviral infections in children.Adv Pediatr Infect Dis. 1996;11:365-88. Adv Pediatr Infect Dis. 1996. PMID: 8718467 Review. No abstract available.
Cited by
-
Recovery of humoral immunity is critical for successful antiviral therapy in disseminated mouse adenovirus type 1 infection.Antimicrob Agents Chemother. 2008 Apr;52(4):1462-71. doi: 10.1128/AAC.01311-07. Epub 2008 Feb 11. Antimicrob Agents Chemother. 2008. PMID: 18268085 Free PMC article.
-
Life-threatening infection in transplant recipients.Crit Care Clin. 2013 Oct;29(4):953-73. doi: 10.1016/j.ccc.2013.06.012. Epub 2013 Aug 8. Crit Care Clin. 2013. PMID: 24094386 Free PMC article. Review.
-
Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation.Blood. 2009 Nov 5;114(19):4283-92. doi: 10.1182/blood-2009-07-232454. Epub 2009 Aug 21. Blood. 2009. PMID: 19700662 Free PMC article. Clinical Trial.
-
Small-molecule screening using a whole-cell viral replication reporter gene assay identifies 2-{[2-(benzoylamino)benzoyl]amino}-benzoic acid as a novel antiadenoviral compound.Antimicrob Agents Chemother. 2010 Sep;54(9):3871-7. doi: 10.1128/AAC.00203-10. Epub 2010 Jun 28. Antimicrob Agents Chemother. 2010. PMID: 20585112 Free PMC article.
-
Human cord blood-derived viral pathogens as the potential threats to the hematopoietic stem cell transplantation safety: A mini review.World J Stem Cells. 2019 Feb 26;11(2):73-83. doi: 10.4252/wjsc.v11.i2.73. World J Stem Cells. 2019. PMID: 30842806 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources